# US 2019/0240468 A1 · Methods and Devices for Treating Parasympathetic Bias Mediated Conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0240468 A1
- Document ID: US20190240468A1
- Status: Published application
- Kind: A1
- Application number: 16/384,347
- Filed: 2019-04-15
- Published: 2019-08-08
- Earliest claimed: 2012-08-29
- Assignees: Palo Alto Investors
- Applicants: Palo Alto Investors
- Inventors: Anthony Joonkyoo Yun; Jeremy Thomas Yun; Eric Foster Yun
- Web page: https://patentgrep.com/patent/US20190240468A1

## CPC

- A61M 37/0015: {by using microneedles}
- A61B 5/02416: {using photoplethysmograph signals, e.g. generated by infrared radiation (A61B5/14552 takes precedence)}
- A61B 5/0816: {Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14542: {for measuring blood gases (A61B5/14551 takes precedence)}
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61H 1/00: Apparatus for passive exercising (A61H5/00 takes precedence); Vibrating apparatus; Chiropractic devices, e.g. body impacting devices, external devices for briefly extending or aligning unbroken bones
- A61M 37/0092: {using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis}
- A61N 1/00: Electrotherapy; Circuits therefor (A61N2/00 takes precedence; irradiation apparatus A61N5/00)
- A61N 1/36014: {External stimulators, e.g. with patch electrodes (external pacemakers A61N1/3625)}
- A61N 1/36017: {with leads or electrodes penetrating the skin}
- A61N 1/3605: {Implantable neurostimulators for stimulating central or peripheral nerve system}
- A61N 1/3606: {adapted for a particular treatment}
- A61N 5/0622: {Optical stimulation for exciting neural tissue}
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61M 2037/0023: {Drug applicators using microneedles}
- A61N 1/36085: {Eating disorders or obesity}
- A61N 1/36167: {Timing, e.g. stimulation onset}
- A61N 2005/0659: {infrared}
- A61N 2005/0663: {Coloured light}
- A61N 2007/0026: {Stimulation of nerve tissue}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Methods for treating a subject for a parasympathetic bias mediated condition are provided. Aspects of the methods include modulating at least a portion of the subject's autonomic nervous system to increase the sympathetic/parasympathetic activity ratio in a manner effective to treat the subject for the parasympathetic bias mediated condition. In some instances, the subject is known to have parasympathetic bias. Also provided are devices that find use in practicing various embodiments of the methods.

## Claims

### Claim 1

A method of treating a subject for a parasympathetic bias mediated condition, the method comprising:
modulating at least a portion of the subject's autonomic nervous system to increase the sympathetic/parasympathetic activity ratio in a manner effective to treat the subject for the parasympathetic bias mediated condition, wherein the subject is known to have parasympathetic bias.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the parasympathetic bias mediated condition is an acute condition.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the parasympathetic bias mediated condition is a predicted adverse response to a stimulus.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the stimulus is therapeutic agent administration.

### Claim 5 (depends on 3)

The method according to claim 3, wherein the stimulus is nutritional ingestion.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the parasympathetic bias mediated condition is a food allergy syndrome condition.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the method comprises decreasing parasympathetic activity.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the method comprises increasing sympathetic activity.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the method comprises employing a paradoxical protocol to modulate the sympathetic/parasympathetic activity ratio.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the sympathetic/parasympathetic activity ratio is modulated via an electrical protocol.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the sympathetic/parasympathetic activity ratio is modulated via a pharmacological protocol.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the pharmacological protocol is an acute protocol.

### Claim 13 (depends on 11)

The method according to claim 11, wherein the pharmacological protocol is a chronic protocol.

### Claim 14 (depends on 1)

The method according to claim 1, wherein the subject is known to have vagal bias.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the vagal bias is characterized by one or more of vagal dominance, vagal hypersensitivity and sympathetic insufficiency.

### Claim 16 (depends on 1)

The method according to claim 1, wherein the method further comprises determining whether the subject has parasympathetic bias.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the subject is a mammal.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the mammal is a human.

### Claim 19

A method of determining a treatment protocol for a subject having a parasympathetic bias mediated condition, the method comprising:
assessing whether the subject has parasympathetic bias; and
determining a treatment protocol for the subject based on whether the subject has parasympathetic bias.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the treatment protocol is administration of a therapeutic agent.
